标题
Therapeutic targeting of the IL-13 pathway in skin inflammation
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2020-12-04
DOI
10.1080/1744666x.2020.1858802
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus
- (2020) Masanori Fujii BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Efficacy of biologics in atopic dermatitis
- (2020) Jianni Wu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
- (2020) Emma Guttman-Yassky et al. JAMA Dermatology
- Implications of IL-13Rα2 in atopic skin inflammation
- (2020) Masutaka Furue et al. ALLERGOLOGY INTERNATIONAL
- Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch
- (2020) Santosh K. Mishra et al. Cell Reports
- Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
- (2020) Aaron M. Drucker et al. JAMA Dermatology
- Microbiome Composition and Its Impact on the Development of Allergic Diseases
- (2020) Diego G. Peroni et al. Frontiers in Immunology
- Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis
- (2020) Shelley K. Uppal et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial
- (2020) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
- (2020) Jonathan I. Silverberg et al. JAMA Dermatology
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
- (2020) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Atopic dermatitis endotypes and implications for targeted therapeutics
- (2019) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic dermatitis is an IL-13 dominant disease with greater molecular heterogeneity compared to psoriasis
- (2019) Lam C. Tsoi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
- (2019) Sarah Faiz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Current and emerging biologic and small molecule therapies for atopic dermatitis
- (2019) Randall Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Understanding the Immune Landscape in Atopic Dermatitis: The Era of Biologics and Emerging Therapeutic Approaches
- (2019) Matthew Moyle et al. EXPERIMENTAL DERMATOLOGY
- Pathophysiology of atopic dermatitis: Clinical implications
- (2019) Jihyun Kim et al. ALLERGY AND ASTHMA PROCEEDINGS
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- What’s New in Atopic Dermatitis
- (2019) Yael Renert-Yuval et al. DERMATOLOGIC CLINICS
- Dupilumab-asssoziierte Abheilung einer Alopecia areata bei Atopischem Ekzem
- (2019) Nora Aszodi et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- Case of alopecia areata during dupilumab treatment for atopic dermatitis
- (2019) Naoko Kanda et al. JOURNAL OF DERMATOLOGY
- Periostin is induced by IL-4/IL-13 in dermal fibroblasts and promotes RhoA/ROCK pathway-mediated TGF-β1 secretion in abnormal scar formation
- (2019) Daisuke Maeda et al. Journal of Plastic Surgery and Hand Surgery
- Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
- (2019) Thomas Bieber ALLERGY
- Transcriptional Control and Transcriptomic Analysis of Lipid Metabolism in Skin barrier formation and Atopic Dermatitis (AD)
- (2019) Nilika Bhattacharya et al. Expert Review of Proteomics
- Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes
- (2019) Dugarmaa Ulzii et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
- (2019) Mette Deleuran et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
- (2019) Julie K. Nguyen et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Chitinase 3‐like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation
- (2019) Eun Ji Kwak et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mechanisms of Dupilumab
- (2019) Hani Harb et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis
- (2019) Taylor E. Woo et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase II a open‐label trial and subsequent phase III open‐label extension
- (2019) M.J. Cork et al. BRITISH JOURNAL OF DERMATOLOGY
- The IL ‐13– OVOL 1– FLG axis in atopic dermatitis
- (2019) Kazuhisa Furue et al. IMMUNOLOGY
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-33 in atopic dermatitis
- (2019) Yasutomo Imai JOURNAL OF DERMATOLOGICAL SCIENCE
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
- (2019) Eric L. Simpson et al. JAMA Dermatology
- Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis
- (2019) Giulia Gasparini et al. CYTOKINE
- The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
- (2019) Giancarlo Marone et al. Frontiers in Pharmacology
- The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation
- (2018) Yasutaka Mitamura et al. ALLERGY
- Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
- (2018) James E. Frampton et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond
- (2018) Danielle Karo-Atar et al. BIODRUGS
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Recent evolution of the human skin barrier
- (2018) Erin A. Brettmann et al. EXPERIMENTAL DERMATOLOGY
- Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells
- (2018) Timotheus Y.F. Halim et al. IMMUNITY
- Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
- (2018) Kenji Kabashima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- New mechanism underlying IL-31–induced atopic dermatitis
- (2018) Jianghui Meng et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Serum from Asian patients with atopic dermatitis is characterized by T H 2/T H 22 activation, which is highly correlated with nonlesional skin measures
- (2018) Huei-Chi Wen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship
- (2018) Joan A. Geoghegan et al. TRENDS IN MICROBIOLOGY
- Significance of Skin Barrier Dysfunction in Atopic Dermatitis
- (2018) Byung Eui Kim et al. Allergy Asthma & Immunology Research
- Microbiome in the Gut-Skin Axis in Atopic Dermatitis
- (2018) So-Yeon Lee et al. Allergy Asthma & Immunology Research
- Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
- (2018) Ilkka S. Junttila Frontiers in Immunology
- Atopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
- (2018) Riana D. Sanyal et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies
- (2018) Sathyadevi Venkataramani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- (2018) B Barroso-García et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hair Regrowth in a Patient With Long-standing Alopecia Totalis and Atopic Dermatitis Treated With Dupilumab
- (2018) Lauren R. Penzi et al. JAMA Dermatology
- Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine
- (2018) Debajyoti Ghosh et al. Frontiers in Immunology
- Commonality of the IL-4/IL-13 pathway in atopic diseases
- (2017) Namita A. Gandhi et al. Expert Review of Clinical Immunology
- Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
- (2017) Thomas Bieber et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis
- (2017) Shunya Mashiko et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis
- (2017) Gaku Tsuji et al. Cell Death & Disease
- Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy
- (2016) Sjors A. Koppes et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Early-onset pediatric atopic dermatitis is T H 2 but also T H 17 polarized in skin
- (2016) Hitokazu Esaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and β-Defensins in Filaggrin-Deficient Skin Equivalents
- (2016) Stefan Hönzke et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses
- (2016) Chang-Min Lee et al. Nature Communications
- Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria
- (2016) Youin Bae et al. Allergy Asthma & Immunology Research
- Modulation of pulmonary fibrosis by IL-13Rα2
- (2015) Robert V. Lumsden et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co
- (2015) O. Nemoto et al. BRITISH JOURNAL OF DERMATOLOGY
- Commentary: IL-4 and IL-13 receptors and signaling
- (2015) Sarah M. McCormick et al. CYTOKINE
- The differential expression of IL-4 and IL-13 and its impact on type-2 immunity
- (2015) Katherine Bao et al. CYTOKINE
- IL-33 impacts on the skin barrier by downregulating the expression of filaggrin
- (2015) Jenny Seltmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
- (2015) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin
- (2015) K. Szegedi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Targeting key proximal drivers of type 2 inflammation in disease
- (2015) Namita A. Gandhi et al. NATURE REVIEWS DRUG DISCOVERY
- Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics
- (2015) Yasaman Mansouri et al. Journal of Clinical Medicine
- IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants
- (2014) Charani Ranasinghe et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 Ligand
- (2014) Naoko Murakami-Satsutani et al. ALLERGOLOGY INTERNATIONAL
- Formation and functions of the corneocyte lipid envelope (CLE)
- (2013) Peter M. Elias et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata
- (2013) M.K. Tembhre et al. BRITISH JOURNAL OF DERMATOLOGY
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
- (2013) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The role of IL-22 and Th22 cells in human skin diseases
- (2013) Hideki Fujita JOURNAL OF DERMATOLOGICAL SCIENCE
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- Cytokine mediated tissue fibrosis
- (2012) Lee A. Borthwick et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
- (2012) H. H. Kong et al. GENOME RESEARCH
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Follow-Up Study of the First Genome-Wide Association Scan in Alopecia Areata: IL13 and KIAA0350 as Susceptibility Loci Supported with Genome-Wide Significance
- (2012) Dagny Jagielska et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
- (2011) Mark Boguniewicz et al. IMMUNOLOGICAL REVIEWS
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities
- (2011) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Low diversity of the gut microbiota in infants with atopic eczema
- (2011) Thomas R. Abrahamsson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-13 Induces Skin Fibrosis in Atopic Dermatitis by Thymic Stromal Lymphopoietin
- (2011) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
- (2008) Byung Eui Kim et al. CLINICAL IMMUNOLOGY
- Untangling the Complex Web of IL-4- and IL-13-Mediated Signaling Pathways
- (2008) M. Wills-Karp et al. Science Signaling
- Reduced diversity in the early fecal microbiota of infants with atopic eczema
- (2007) Mei Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started